Sponsor

U.S. Bioscience

Clinical research sponsor

Published trials5

Recruiting shown0

Roles1

SourceClinicalTrials.gov

Clinical trials

5 shown

A Compassionate Treatment Protocol for the Use of Trimetrexate Glucuronate With Leucovorin Protection for Patients With Pneumocystis Carinii Pneumonia.NCT00002102 · lead sponsor

COMPLETED

Randomized Phase I Study of Trimetrexate Glucuronate (TMTX) With Leucovorin (LCV) Protection Plus Dapsone Versus Trimethoprim / Sulfamethoxazole (TMP/SMX) for Treatment of Moderately Severe Episodes of Pneumocystis Carinii PneumoniaNCT00002120 · lead sponsor

COMPLETED

A Study of Trimetrexate Plus Leucovorin in Children With Pneumocystis Carinii PneumoniaNCT00002317 · lead sponsor

COMPLETED

A Study of Neutrexin Plus Leucovorin in the Treatment of Pneumocystis Carinii Pneumonia (PCP)NCT00002434 · lead sponsor

COMPLETED

A Compassionate Treatment Protocol for the Use of Trimetrexate Glucuronate (Neutrexin) With Leucovorin Protection for European Adult Patients (>= 13 Years Old) With Pneumocystis Carinii PneumoniaNCT00002103 · lead sponsor

COMPLETED

Sponsor roles

lead sponsor5

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.